Front Row Advisors’s Sanofi SNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-218
| Closed | -$10.6K | – | 790 |
|
2024
Q2 | $10.6K | Sell |
218
-418
| -66% | -$20.3K | ﹤0.01% | 556 |
|
2024
Q1 | $30.9K | Buy |
+636
| New | +$30.9K | 0.01% | 319 |
|
2023
Q4 | – | Sell |
-715
| Closed | -$38.4K | – | 757 |
|
2023
Q3 | $38.4K | Sell |
715
-2
| -0.3% | -$107 | 0.02% | 263 |
|
2023
Q2 | $39K | Sell |
717
-246
| -26% | -$13.4K | 0.02% | 272 |
|
2023
Q1 | $52K | Buy |
963
+53
| +6% | +$2.86K | 0.02% | 243 |
|
2022
Q4 | $44K | Buy |
910
+80
| +10% | +$3.87K | 0.02% | 256 |
|
2022
Q3 | $32K | Buy |
830
+312
| +60% | +$12K | 0.02% | 289 |
|
2022
Q2 | $26K | Buy |
518
+61
| +13% | +$3.06K | 0.01% | 335 |
|
2022
Q1 | $23K | Buy |
457
+121
| +36% | +$6.09K | 0.01% | 392 |
|
2021
Q4 | $17K | Buy |
336
+113
| +51% | +$5.72K | 0.01% | 466 |
|
2021
Q3 | $11K | Buy |
223
+33
| +17% | +$1.63K | ﹤0.01% | 545 |
|
2021
Q2 | $10K | Buy |
190
+62
| +48% | +$3.26K | ﹤0.01% | 572 |
|
2021
Q1 | $6K | Hold |
128
| – | – | ﹤0.01% | 699 |
|
2020
Q4 | $6K | Sell |
128
-100
| -44% | -$4.69K | ﹤0.01% | 656 |
|
2020
Q3 | $12K | Sell |
228
-151
| -40% | -$7.95K | 0.01% | 472 |
|
2020
Q2 | $19K | Buy |
379
+49
| +15% | +$2.46K | 0.01% | 357 |
|
2020
Q1 | $15K | Sell |
330
-2
| -0.6% | -$91 | 0.01% | 385 |
|
2019
Q4 | $17K | Hold |
332
| – | – | 0.01% | 357 |
|
2019
Q3 | $15K | Sell |
332
-2
| -0.6% | -$90 | 0.01% | 369 |
|
2019
Q2 | $14K | Sell |
334
-64
| -16% | -$2.68K | 0.01% | 377 |
|
2019
Q1 | $18K | Hold |
398
| – | – | 0.01% | 338 |
|
2018
Q4 | $17K | Hold |
398
| – | – | 0.01% | 320 |
|
2018
Q3 | $17 | Sell |
398
-2
| -0.5% | – | 0.01% | 332 |
|
2018
Q2 | $17 | Buy |
400
+71
| +22% | +$3 | 0.01% | 359 |
|
2018
Q1 | $13K | Sell |
329
-5
| -1% | -$198 | 0.01% | 406 |
|
2017
Q4 | $14K | Buy |
+334
| New | +$14K | 0.01% | 389 |
|